Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCrossword Cybersecurity Regulatory News (CCS)

  • This share is currently suspended. It was suspended at a price of 1.75
  • There is currently no data for CCS

Exercise of options

21 Dec 2018 14:53

RNS Number : 3273L
Crossword Cybersecurity PLC
21 December 2018
 

21 December 2018

 

Crossword Cybersecurity plc

Exercise of options

Crossword Cybersecurity plc (AIM: CCS, "Crossword", the "Company" or the "Group"), the technology and consulting company focusing on the cyber security sector, has received a notice exercising options to acquire 666 ordinary shares of 5p each ("Ordinary Shares") at a price of £1.90 pence per Ordinary Share.

Settlement and dealings

Application will be made for the admission of 666 Ordinary Shares, pursuant to the option exercise, which rank pari passu with the Company's existing issued Ordinary Shares, to be admitted to trading on AIM. Dealings on AIM are expected to commence at 8:00am on or around 4 January 2019 ("Admission").

Total Voting Rights

For the purposes of the Financial Conduct Authority's Disclosure Guidance and Transparency Rules ("DTRs"), following Admission, Crossword will have 4,680,396 Ordinary Shares in issue with voting rights attached. Crossword holds no shares in treasury. This figure of 4,680,396 may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company, under the DTRs.

The information contained within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

Contacts

Crossword Cybersecurity plc

Tel: +44 (0) 20 8973 2350

Email: info@crosswordcybersecurity.com

Tom Ilube, Chief Executive Officer

Mary Dowd, Finance Director

 

Grant Thornton (Nominated Adviser)

Tel: +44 (0) 20 7383 5100

Colin Aaronson / Jamie Barklem / Samuel Rowe

Hybridan LLP (Broker)

Tel: +44 (0)203 764 2341

Claire Louise Noyce

 

About Crossword Cybersecurity plc

Crossword Cybersecurity plc focuses on the development and commercialisation of university research-based cyber security related software and cyber security consulting. The Group's specialist cyber security product development and software engineering teams work with its university partners to develop the research concept into a fully-fledged commercial product that it will then take to market. The Group's aim is to build up a portfolio of revenue generating, intellectual property based, cyber security products. Rizikon Assurance, Crossword's first product, is a SaaS platform that enables medium to large companies to assess the cyber maturity and GDPR readiness of their suppliers. Crossword's team of expert cyber security consultants leverages years of experience in national security, defence and commercial cyber intelligence and operations to provide bespoke advice tailored to its clients' business needs. 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
ALSPGGUAPUPRGCG
Date   Source Headline
18th Nov 20247:00 amRNSCancellation - Crossword Cybersecurity plc
15th Oct 20244:45 pmRNSBusiness and assets sale update. Nomad resignation
11th Oct 20247:00 amRNSFinancial Update and Proposed Asset Sale
1st Oct 20247:30 amRNSSuspension - Crossword Cybersecurity plc
27th Sep 20244:45 pmRNSComment on Delay to Publication of Accounts
27th Sep 20242:48 pmRNSDelay to Interim Accounts. Suspension of Shares
20th Sep 202411:51 amRNSResult of General Meeting
4th Sep 20247:00 amRNSShareholder Circular and Notice of General Meeting
30th Aug 20247:00 amRNSAppointment of part-time Head of Finance
14th Aug 20247:00 amRNSCFO resignation and £1m pa cost reductions
31st Jul 20244:01 pmRNSHolding(s) in Company
31st Jul 20247:00 amRNSTotal Voting Rights
25th Jul 20247:00 amRNSHolding(s) in Company
18th Jul 20247:00 amRNSEquity fundraising incl. Director's subscription
18th Jun 20247:00 amRNSRizikon Partnership with Global Defence Company
23rd May 20243:11 pmRNSResult of AGM
21st May 20247:00 amRNSChair and CEO Transition Plans
16th Apr 20247:00 amRNSCFO Transition
12th Apr 20242:47 pmRNSHolding(s) in Company
11th Apr 20245:30 pmRNSHolding(s) in Company
11th Apr 20247:00 amRNSNew Head of Consulting
9th Apr 20247:00 amRNSSecurity in the Caribbean
3rd Apr 20247:00 amRNSBoard Appointment
28th Mar 20247:00 amRNSTotal Voting Rights
26th Mar 20247:00 amRNSLaunches new CyberAI Practice
15th Mar 20242:15 pmRNSHolding(s) in Company
14th Mar 20245:46 pmRNSHolding(s) in Company
12th Mar 20247:00 amRNSIssue of Shares
5th Mar 20247:00 amRNSIssue of Loan Notes and Related Party Transactions
27th Feb 20247:00 amRNSLaunch of Trillion HarVitsa
15th Feb 20247:00 amRNSPartnership with TD Synnex
2nd Jan 20247:00 amRNSDirectorate Change
28th Nov 20237:00 amRNSTrading Update
25th Oct 20231:56 pmRNSDirector/PDMR Shareholding
16th Oct 20237:00 amRNSIssue of Loan Notes
28th Sep 20237:00 amRNSInterim Results & Notice of Investor Presentation
1st Sep 20233:37 pmRNSDirector/PDMR Shareholding
31st Aug 20237:00 amRNSH1 Trading Update & Issue of Loan Notes
27th Jul 202312:11 pmRNSResult of General Meeting
10th Jul 20237:00 amRNSShareholder Circular and Notice of AGM
6th Jun 20237:00 amRNSThreat Intelligence Monitoring Contract
30th May 20237:00 amRNSShare Option Awards
24th May 20231:24 pmRNSDirector/PDMR Shareholding
23rd May 202310:29 amRNSDirector/PDMR Shareholding
23rd May 20237:00 amRNSRelated Party Transaction
22nd May 202311:23 amRNSResult of AGM
16th May 20239:53 amRNSDirector/PDMR Shareholding
15th May 20232:59 pmRNSDirector/PDMR Shareholding
11th May 20237:00 amRNSTop 100 Cybersecurity firms
9th May 20234:06 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.